Inspire Advisors LLC Has $581,000 Stock Holdings in InMode Ltd. (NASDAQ:INMD)

Inspire Advisors LLC lifted its holdings in shares of InMode Ltd. (NASDAQ:INMD) by 11.5% during the 4th quarter, HoldingsChannel.com reports. The firm owned 34,766 shares of the healthcare company’s stock after buying an additional 3,574 shares during the period. Inspire Advisors LLC’s holdings in InMode were worth $581,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of the business. National Bank of Canada FI boosted its holdings in InMode by 6.2% in the third quarter. National Bank of Canada FI now owns 9,985 shares of the healthcare company’s stock worth $169,000 after purchasing an additional 579 shares in the last quarter. Harvey Capital Management Inc. boosted its stake in shares of InMode by 1.4% during the 4th quarter. Harvey Capital Management Inc. now owns 51,490 shares of the healthcare company’s stock worth $860,000 after acquiring an additional 700 shares in the last quarter. Franklin Resources Inc. boosted its stake in shares of InMode by 4.6% during the 3rd quarter. Franklin Resources Inc. now owns 17,559 shares of the healthcare company’s stock worth $292,000 after acquiring an additional 768 shares in the last quarter. Meritage Portfolio Management increased its holdings in shares of InMode by 9.5% during the 3rd quarter. Meritage Portfolio Management now owns 14,765 shares of the healthcare company’s stock valued at $250,000 after acquiring an additional 1,284 shares during the last quarter. Finally, Marco Investment Management LLC raised its stake in shares of InMode by 5.2% in the 4th quarter. Marco Investment Management LLC now owns 37,835 shares of the healthcare company’s stock valued at $632,000 after acquiring an additional 1,860 shares in the last quarter. Institutional investors own 68.04% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on INMD. Barclays upped their target price on InMode from $26.00 to $29.00 and gave the stock an “overweight” rating in a research report on Wednesday, February 5th. Needham & Company LLC reiterated a “hold” rating on shares of InMode in a research note on Tuesday, February 4th. Three investment analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat, InMode currently has an average rating of “Hold” and a consensus target price of $22.25.

InMode Stock Down 2.8 %

INMD opened at $18.81 on Wednesday. The stock’s 50 day moving average price is $17.84 and its two-hundred day moving average price is $17.57. The firm has a market capitalization of $1.31 billion, a P/E ratio of 8.00 and a beta of 2.07. InMode Ltd. has a 12-month low of $14.87 and a 12-month high of $22.00.

InMode Company Profile

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures.